The global Vital Organs Support Systems and Medical Bionics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Abiomed, Inc.
Abbott Laboratories
Asahi Kasei Corporation
Baxter International Inc
Boston Scientific Corporation
Cochlear Ltd.
Edwards Lifesciences Corporation
Jarvik Heart, Inc.
Medtronic Plc.
Össur Americas, Inc.
Second Sight Medical Products, Inc.
SynCardia Systems LLC
By Types:
Hospitals
Ambulatory Surgical Centers
Others
By Applications:
Vital Organs Support Systems
Medical Bionics
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Vital Organs Support Systems and Medical Bionics Market Size Analysis from 2023 to 2028
1.5.1 Global Vital Organs Support Systems and Medical Bionics Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Vital Organs Support Systems and Medical Bionics Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Vital Organs Support Systems and Medical Bionics Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Vital Organs Support Systems and Medical Bionics Industry Impact
Chapter 2 Global Vital Organs Support Systems and Medical Bionics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Vital Organs Support Systems and Medical Bionics (Volume and Value) by Type
2.1.1 Global Vital Organs Support Systems and Medical Bionics Consumption and Market Share by Type (2017-2022)
2.1.2 Global Vital Organs Support Systems and Medical Bionics Revenue and Market Share by Type (2017-2022)
2.2 Global Vital Organs Support Systems and Medical Bionics (Volume and Value) by Application
2.2.1 Global Vital Organs Support Systems and Medical Bionics Consumption and Market Share by Application (2017-2022)
2.2.2 Global Vital Organs Support Systems and Medical Bionics Revenue and Market Share by Application (2017-2022)
2.3 Global Vital Organs Support Systems and Medical Bionics (Volume and Value) by Regions
2.3.1 Global Vital Organs Support Systems and Medical Bionics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Vital Organs Support Systems and Medical Bionics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Vital Organs Support Systems and Medical Bionics Consumption by Regions (2017-2022)
4.2 North America Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
4.10 South America Vital Organs Support Systems and Medical Bionics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Vital Organs Support Systems and Medical Bionics Market Analysis
5.1 North America Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
5.1.1 North America Vital Organs Support Systems and Medical Bionics Market Under COVID-19
5.2 North America Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
5.3 North America Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
5.4 North America Vital Organs Support Systems and Medical Bionics Consumption by Top Countries
5.4.1 United States Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
5.4.2 Canada Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
5.4.3 Mexico Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 6 East Asia Vital Organs Support Systems and Medical Bionics Market Analysis
6.1 East Asia Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
6.1.1 East Asia Vital Organs Support Systems and Medical Bionics Market Under COVID-19
6.2 East Asia Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
6.3 East Asia Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
6.4 East Asia Vital Organs Support Systems and Medical Bionics Consumption by Top Countries
6.4.1 China Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
6.4.2 Japan Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
6.4.3 South Korea Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 7 Europe Vital Organs Support Systems and Medical Bionics Market Analysis
7.1 Europe Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
7.1.1 Europe Vital Organs Support Systems and Medical Bionics Market Under COVID-19
7.2 Europe Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
7.3 Europe Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
7.4 Europe Vital Organs Support Systems and Medical Bionics Consumption by Top Countries
7.4.1 Germany Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
7.4.2 UK Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
7.4.3 France Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
7.4.4 Italy Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
7.4.5 Russia Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
7.4.6 Spain Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
7.4.7 Netherlands Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
7.4.8 Switzerland Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
7.4.9 Poland Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 8 South Asia Vital Organs Support Systems and Medical Bionics Market Analysis
8.1 South Asia Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
8.1.1 South Asia Vital Organs Support Systems and Medical Bionics Market Under COVID-19
8.2 South Asia Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
8.3 South Asia Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
8.4 South Asia Vital Organs Support Systems and Medical Bionics Consumption by Top Countries
8.4.1 India Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
8.4.2 Pakistan Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Vital Organs Support Systems and Medical Bionics Market Analysis
9.1 Southeast Asia Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
9.1.1 Southeast Asia Vital Organs Support Systems and Medical Bionics Market Under COVID-19
9.2 Southeast Asia Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
9.3 Southeast Asia Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
9.4 Southeast Asia Vital Organs Support Systems and Medical Bionics Consumption by Top Countries
9.4.1 Indonesia Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
9.4.2 Thailand Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
9.4.3 Singapore Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
9.4.4 Malaysia Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
9.4.5 Philippines Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
9.4.6 Vietnam Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
9.4.7 Myanmar Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 10 Middle East Vital Organs Support Systems and Medical Bionics Market Analysis
10.1 Middle East Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
10.1.1 Middle East Vital Organs Support Systems and Medical Bionics Market Under COVID-19
10.2 Middle East Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
10.3 Middle East Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
10.4 Middle East Vital Organs Support Systems and Medical Bionics Consumption by Top Countries
10.4.1 Turkey Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
10.4.3 Iran Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
10.4.5 Israel Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
10.4.6 Iraq Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
10.4.7 Qatar Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
10.4.8 Kuwait Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
10.4.9 Oman Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 11 Africa Vital Organs Support Systems and Medical Bionics Market Analysis
11.1 Africa Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
11.1.1 Africa Vital Organs Support Systems and Medical Bionics Market Under COVID-19
11.2 Africa Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
11.3 Africa Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
11.4 Africa Vital Organs Support Systems and Medical Bionics Consumption by Top Countries
11.4.1 Nigeria Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
11.4.2 South Africa Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
11.4.3 Egypt Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
11.4.4 Algeria Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
11.4.5 Morocco Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 12 Oceania Vital Organs Support Systems and Medical Bionics Market Analysis
12.1 Oceania Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
12.2 Oceania Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
12.3 Oceania Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
12.4 Oceania Vital Organs Support Systems and Medical Bionics Consumption by Top Countries
12.4.1 Australia Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
12.4.2 New Zealand Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 13 South America Vital Organs Support Systems and Medical Bionics Market Analysis
13.1 South America Vital Organs Support Systems and Medical Bionics Consumption and Value Analysis
13.1.1 South America Vital Organs Support Systems and Medical Bionics Market Under COVID-19
13.2 South America Vital Organs Support Systems and Medical Bionics Consumption Volume by Types
13.3 South America Vital Organs Support Systems and Medical Bionics Consumption Structure by Application
13.4 South America Vital Organs Support Systems and Medical Bionics Consumption Volume by Major Countries
13.4.1 Brazil Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
13.4.2 Argentina Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
13.4.3 Columbia Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
13.4.4 Chile Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
13.4.5 Venezuela Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
13.4.6 Peru Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
13.4.8 Ecuador Vital Organs Support Systems and Medical Bionics Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Vital Organs Support Systems and Medical Bionics Business
14.1 Abiomed, Inc.
14.1.1 Abiomed, Inc. Company Profile
14.1.2 Abiomed, Inc. Vital Organs Support Systems and Medical Bionics Product Specification
14.1.3 Abiomed, Inc. Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Abbott Laboratories
14.2.1 Abbott Laboratories Company Profile
14.2.2 Abbott Laboratories Vital Organs Support Systems and Medical Bionics Product Specification
14.2.3 Abbott Laboratories Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Asahi Kasei Corporation
14.3.1 Asahi Kasei Corporation Company Profile
14.3.2 Asahi Kasei Corporation Vital Organs Support Systems and Medical Bionics Product Specification
14.3.3 Asahi Kasei Corporation Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Baxter International Inc
14.4.1 Baxter International Inc Company Profile
14.4.2 Baxter International Inc Vital Organs Support Systems and Medical Bionics Product Specification
14.4.3 Baxter International Inc Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Boston Scientific Corporation
14.5.1 Boston Scientific Corporation Company Profile
14.5.2 Boston Scientific Corporation Vital Organs Support Systems and Medical Bionics Product Specification
14.5.3 Boston Scientific Corporation Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Cochlear Ltd.
14.6.1 Cochlear Ltd. Company Profile
14.6.2 Cochlear Ltd. Vital Organs Support Systems and Medical Bionics Product Specification
14.6.3 Cochlear Ltd. Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Edwards Lifesciences Corporation
14.7.1 Edwards Lifesciences Corporation Company Profile
14.7.2 Edwards Lifesciences Corporation Vital Organs Support Systems and Medical Bionics Product Specification
14.7.3 Edwards Lifesciences Corporation Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Jarvik Heart, Inc.
14.8.1 Jarvik Heart, Inc. Company Profile
14.8.2 Jarvik Heart, Inc. Vital Organs Support Systems and Medical Bionics Product Specification
14.8.3 Jarvik Heart, Inc. Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Medtronic Plc.
14.9.1 Medtronic Plc. Company Profile
14.9.2 Medtronic Plc. Vital Organs Support Systems and Medical Bionics Product Specification
14.9.3 Medtronic Plc. Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Össur Americas, Inc.
14.10.1 Össur Americas, Inc. Company Profile
14.10.2 Össur Americas, Inc. Vital Organs Support Systems and Medical Bionics Product Specification
14.10.3 Össur Americas, Inc. Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Second Sight Medical Products, Inc.
14.11.1 Second Sight Medical Products, Inc. Company Profile
14.11.2 Second Sight Medical Products, Inc. Vital Organs Support Systems and Medical Bionics Product Specification
14.11.3 Second Sight Medical Products, Inc. Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 SynCardia Systems LLC
14.12.1 SynCardia Systems LLC Company Profile
14.12.2 SynCardia Systems LLC Vital Organs Support Systems and Medical Bionics Product Specification
14.12.3 SynCardia Systems LLC Vital Organs Support Systems and Medical Bionics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Vital Organs Support Systems and Medical Bionics Market Forecast (2023-2028)
15.1 Global Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Vital Organs Support Systems and Medical Bionics Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Vital Organs Support Systems and Medical Bionics Value and Growth Rate Forecast (2023-2028)
15.2 Global Vital Organs Support Systems and Medical Bionics Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Vital Organs Support Systems and Medical Bionics Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Vital Organs Support Systems and Medical Bionics Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Vital Organs Support Systems and Medical Bionics Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Vital Organs Support Systems and Medical Bionics Consumption Forecast by Type (2023-2028)
15.3.2 Global Vital Organs Support Systems and Medical Bionics Revenue Forecast by Type (2023-2028)
15.3.3 Global Vital Organs Support Systems and Medical Bionics Price Forecast by Type (2023-2028)
15.4 Global Vital Organs Support Systems and Medical Bionics Consumption Volume Forecast by Application (2023-2028)
15.5 Vital Organs Support Systems and Medical Bionics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
The Industrial HEPA Vacuum Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Nuclear Medicine Cyclotron Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
In 2018, the local hemostatic market in Korea is estimated to have reached US$*** million based on initial supply price and US$*** million based on end user (medical institution) purchase price.Korean hemostatic market is expected to grow at an average annual rate of ***% over the five year...
As of 2022, the total market size of intraocular lenses in Korea is estimated to be approximately ***units (***USD) by manufacturers'/importers' initial selling unit and ***units (***USD) by medical institutions' purchase unit.
It is estimated that the relatively high production/import volume...
In this report, medical AI is defined as artificial intelligence used across the healthcare industry. AI-enabled medical devices are in particular referred to devices which assist healthcare providers in diagnosing, managing and/or predicting diseases through analyzing medical big data with artifici...
In Korea, Private Health Insurance means private insurance plans introduced to supplement the National Health Insurance Service, the nationwide public health insurance system.
When the insured with illness or injury receive medical treatments such as hospital stay, out-patient care or prescri...
As of 2022, the total market size of the wound dressings in Korea is estimated to be approximately USD *** million, about an increase of ***% compared to the previous year. Reimbursement volume is estimated to be approximately USD *** million - around ***% of the entire market.
Afterwards, it...
In 2022, the total market size of dental implants in Korea is estimated to be approxiamately USD ***million at manufacturers/importers' initial selling prices (about *** units, including fixtures and upper parts) and USD *** million at medical institutions' purchase prices.
The dental implants...
Dermal fillers are classified by the MFDS as Class Ⅳ medical devices, with the product classification number B04230.01 (biomaterial graft/prosthesis) or B04230.02 (graft/prosthesis).
According to the , dermal fillers are non-rei...
In 2022, the total market size of anti-adhesion products in Korea is estimated to be approximately USD *** million (manufacturers/importers' initial selling prices) and USD *** million (medical institutions' purchase prices).
While some estimates put the market size at around USD *** million ...